Prospective clinical trial on the learning curve of high-intensity-focused ultrasound for the treatment of breast fibroadenoma

Surgery Today ◽  
2022 ◽  
Author(s):  
Michael Co ◽  
Clement Chen ◽  
Cassandra Lee ◽  
Stephanie Yu ◽  
Ava Kwong
Keyword(s):  
Clinical Trial ◽  
Learning Curve ◽  
High Intensity ◽  
Focused Ultrasound ◽  
High Intensity Focused Ultrasound ◽  
Prospective Clinical Trial ◽  
Breast Fibroadenoma

scholarly journals High intensity focused ultrasound (HIFU) for the treatment of symptomatic breast fibroadenoma

2018 ◽  
Vol 35 (1) ◽  
pp. 463-470
Author(s):  
M. Hahn ◽  
R. Fugunt ◽  
B. Schoenfisch ◽  
E. Oberlechner ◽  
I.V. Gruber ◽  
...  
Keyword(s):  
High Intensity ◽  
Focused Ultrasound ◽  
High Intensity Focused Ultrasound ◽  
Breast Fibroadenoma ◽  
Symptomatic Breast

scholarly journals Lessons learned during implementation of MR-guided High-Intensity Focused Ultrasound treatment of uterine fibroids

2021 ◽  
Vol 12 (1) ◽  
Author(s):  
K. J. Anneveldt ◽  
I. M. Verpalen ◽  
I. M. Nijholt ◽  
J. R. Dijkstra ◽  
R. D. van den Hoed ◽  
...  
Keyword(s):  
Learning Curve ◽  
Patient Selection ◽  
High Intensity ◽  
Focused Ultrasound ◽  
Uterine Fibroids ◽  
Lessons Learned ◽  
High Intensity Focused Ultrasound ◽  
Patient Counseling ◽  
Hifu Treatment ◽  
Medical Specialists

Abstract Background Although promising results have been reported for Magnetic Resonance image-guided High-Intensity Focused Ultrasound (MR-HIFU) treatment of uterine fibroids, this treatment is not yet widely implemented in clinical practice. During the implementation of a new technology, lessons are learned and an institutional learning-curve often has to be completed. The primary aim of our prospective cohort study was to characterize our learning-curve based on our clinical outcomes. Secondary aims included identifying our lessons learned during implementation of MR-HIFU on a technical, patient selection, patient counseling, medical specialists and organizational level. Results Our first seventy patients showed significant symptom reduction and improvement of quality of life at 3, 6 and 12 months after MR-HIFU treatment compared to baseline. After the first 25 cases, a clear plateau phase was reached in terms of failed treatments. The median non-perfused volume percentage of these first 25 treatments was 44.6% (range: 0–99.7), compared to a median of 74.7% (range: 0–120.6) for the subsequent treatments. Conclusions Our findings describe the learning-curve during the implementation of MR-HIFU and include straightforward suggestions to shorten learning-curves for future users. Moreover, the lessons we learned on technique, patient selection, patient counseling, medical specialists and organization, together with the provided supplements, may be of benefit to other institutions aiming to implement MR-HIFU treatment of uterine fibroids. Trial registration ISRCTN14634593. Registered January 12, 2021—Retrospectively registered, https://www.isrctn.com/ISRCTN14634593.

scholarly journals MP18-01 WHOLE GLAND SALVAGE HIGH INTENSITY FOCUSED ULTRASOUND OF PROSTATE: INTERMEDIATE TERM RESULTS OF PROSPECTIVE PHASE II CLINICAL TRIAL

2016 ◽  
Vol 195 (4S) ◽  
Author(s):  
Khurram Siddiqui ◽  
Michele Billia ◽  
Philippe Violette ◽  
Andrew Arifin ◽  
KimChi Tran ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase Ii ◽  
High Intensity ◽  
Focused Ultrasound ◽  
High Intensity Focused Ultrasound ◽  
Phase Ii Clinical Trial ◽  
Prospective Phase

High Intensity Focused Ultrasound for Radiorecurrent Prostate Cancer: A North American Clinical Trial

2018 ◽  
Vol 199 (1) ◽  
pp. 133-139 ◽  
Author(s):  
Tonye A. Jones ◽  
Joseph Chin ◽  
David Mcleod ◽  
Jack Barkin ◽  
Allan Pantuck ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Clinical Trial ◽  
North American ◽  
High Intensity ◽  
Focused Ultrasound ◽  
High Intensity Focused Ultrasound
Sign in / Sign up

Export Citation Format

Share Document